Transition metal(II) complexes with the non-steroidal anti-inflammatory drug oxaprozin: Characterization and biological profile

J Inorg Biochem. 2023 Jun:243:112196. doi: 10.1016/j.jinorgbio.2023.112196. Epub 2023 Mar 17.

Abstract

A series of copper(II), nickel(II) and cobalt(II) complexes with the non-steroidal anti-inflammatory drug oxaprozin (Hoxa) have been synthesized and characterized by diverse techniques. The crystal structures of two copper(II) complexes, namely the dinuclear complex [Cu2(oxa)4(DMF)2] (1) and the polymeric complex {[Cu2(oxa)4]·2MeOH·0.5MeOH}2 (12) were determined by single-crystal X-ray diffraction studies. In order to evaluate in vitro the antioxidant activity of the resultant complexes, their scavenging ability towards 1,1-diphenyl-picrylhydrazyl (DPPH), hydroxyl and 2,2'-azinobis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) radicals was investigated revealing their high effectiveness against these radicals. The binding of the complexes to bovine serum albumin and human serum albumin was examined and the corresponding determined albumin-binding constants showed a tight and reversible interaction. The interaction of the complexes with calf-thymus DNA was monitored by diverse techniques including UV-vis spectroscopy, cyclic voltammetry, DNA-viscosity measurements and competitive studies with ethidium bromide. Intercalation may be proposed as the most possible DNA-interaction mode of the complexes.

Keywords: Binding with albumins; Interaction with calf–thymus DNA; Metal complexes; Oxaprozin; Radical scavenging activity.

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / chemistry
  • Coordination Complexes* / chemistry
  • Copper* / chemistry
  • Crystallography, X-Ray
  • DNA / chemistry
  • Humans
  • Oxaprozin
  • Serum Albumin, Bovine / chemistry

Substances

  • Oxaprozin
  • Copper
  • Coordination Complexes
  • Anti-Inflammatory Agents, Non-Steroidal
  • Serum Albumin, Bovine
  • DNA